{"id":310211,"date":"2026-10-15T11:43:36","date_gmt":"2026-10-15T06:13:36","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=310211"},"modified":"2026-10-15T11:43:36","modified_gmt":"2026-10-15T06:13:36","slug":"formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/","title":{"rendered":"3 Formulation Maker, Glycol Producer and Pizza Chain Stocks With a Strong Future Roadmap: Lincoln Pharmaceuticals, India Glycols and Jubilant FoodWorks"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Lincoln Pharma Rs 542.90, P\/E 11.64. India Glycols Rs 349.85, P\/E 7.58. Jubilant FoodWorks Rs 425.70, P\/E 62.77. Closing prices of 14 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Formulation maker, glycol producer and pizza chain stocks with the clearest long-term roadmaps today include Lincoln Pharma in formulations sold in India and emerging export markets, India Glycols in glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and Jubilant FoodWorks in Domino&#8217;s Pizza stores across India and neighbouring markets, along with newer food brands. FY26 revenue growth was 9.1% at Lincoln Pharma, 11.5% at India Glycols and 17.2% at Jubilant FoodWorks. P\/E stands at 11.64 for Lincoln Pharma (industry 37.59), 7.58 for India Glycols (industry 54.53) and 62.77 for Jubilant FoodWorks (industry 61.79). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company&#8217;s risks need equal attention.<\/p>\n<\/p><\/div>\n<p>Formulation maker, glycol producer and pizza chain stocks give investors exposure to medicines, chemicals and food outlets used every day. Volumes, store additions and margins decide how much of that demand turns into profit.<\/p>\n<p>This list covers three formulation maker, glycol producer and pizza chain stocks: Lincoln Pharmaceuticals for formulations sold in India and emerging export markets, India Glycols for glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock and Jubilant FoodWorks for Domino&#8217;s Pizza stores across India and neighbouring markets, along with newer food brands. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#What_Are_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks\" title=\"What Are Formulation Maker, Glycol Producer and Pizza Chain Stocks?\">What Are Formulation Maker, Glycol Producer and Pizza Chain Stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks_at_a_Glance\" title=\"Formulation Maker, Glycol Producer and Pizza Chain Stocks at a Glance\">Formulation Maker, Glycol Producer and Pizza Chain Stocks at a Glance<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Why_Do_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks_Have_a_Strong_Roadmap_in_India\" title=\"Why Do Formulation Maker, Glycol Producer and Pizza Chain Stocks Have a Strong Roadmap in India?\">Why Do Formulation Maker, Glycol Producer and Pizza Chain Stocks Have a Strong Roadmap in India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Lincoln_Pharmaceuticals_Formulations_for_India_and_Export_Markets_Build_the_Next_Leg\" title=\"Lincoln Pharmaceuticals: Formulations for India and Export Markets Build the Next Leg\">Lincoln Pharmaceuticals: Formulations for India and Export Markets Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#India_Glycols_Green_Chemicals_and_Ethanol_Build_the_Next_Leg\" title=\"India Glycols: Green Chemicals and Ethanol Build the Next Leg\">India Glycols: Green Chemicals and Ethanol Build the Next Leg<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Jubilant_FoodWorks_Dominos_Store_Network_Anchors_the_Roadmap\" title=\"Jubilant FoodWorks: Domino&#8217;s Store Network Anchors the Roadmap\">Jubilant FoodWorks: Domino&#8217;s Store Network Anchors the Roadmap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Best_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks_in_India_Lincoln_Pharma_vs_India_Glycols_vs_Jubilant_FoodWorks_on_Key_Financials\" title=\"Best Formulation Maker, Glycol Producer and Pizza Chain Stocks in India: Lincoln Pharma vs India Glycols vs Jubilant FoodWorks on Key Financials\">Best Formulation Maker, Glycol Producer and Pizza Chain Stocks in India: Lincoln Pharma vs India Glycols vs Jubilant FoodWorks on Key Financials<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#How_to_Evaluate_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks_to_Buy_Before_You_Invest\" title=\"How to Evaluate Formulation Maker, Glycol Producer and Pizza Chain Stocks to Buy Before You Invest\">How to Evaluate Formulation Maker, Glycol Producer and Pizza Chain Stocks to Buy Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Risks_to_Consider_Before_Investing_in_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks\" title=\"Risks to Consider Before Investing in Formulation Maker, Glycol Producer and Pizza Chain Stocks\">Risks to Consider Before Investing in Formulation Maker, Glycol Producer and Pizza Chain Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Final_Take_Which_Stock_Has_the_Strongest_Roadmap\" title=\"Final Take: Which Stock Has the Strongest Roadmap?\">Final Take: Which Stock Has the Strongest Roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#FAQs_on_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks\" title=\"FAQs on Formulation Maker, Glycol Producer and Pizza Chain Stocks\">FAQs on Formulation Maker, Glycol Producer and Pizza Chain Stocks<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Which_are_the_best_formulation_maker_glycol_producer_and_pizza_chain_stocks_in_India_with_a_strong_roadmap\" title=\"Which are the best formulation maker, glycol producer and pizza chain stocks in India with a strong roadmap?\">Which are the best formulation maker, glycol producer and pizza chain stocks in India with a strong roadmap?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Is_Lincoln_Pharmaceuticals_a_good_stock_to_buy_now\" title=\"Is Lincoln Pharmaceuticals a good stock to buy now?\">Is Lincoln Pharmaceuticals a good stock to buy now?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#What_is_the_PE_ratio_of_Lincoln_Pharma_India_Glycols_and_Jubilant_FoodWorks\" title=\"What is the P\/E ratio of Lincoln Pharma, India Glycols and Jubilant FoodWorks?\">What is the P\/E ratio of Lincoln Pharma, India Glycols and Jubilant FoodWorks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Which_of_these_formulation_maker_glycol_producer_and_pizza_chain_stocks_has_the_highest_return_on_equity\" title=\"Which of these formulation maker, glycol producer and pizza chain stocks has the highest return on equity?\">Which of these formulation maker, glycol producer and pizza chain stocks has the highest return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#What_are_the_risks_of_investing_in_formulation_maker_glycol_producer_and_pizza_chain_stocks\" title=\"What are the risks of investing in formulation maker, glycol producer and pizza chain stocks?\">What are the risks of investing in formulation maker, glycol producer and pizza chain stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#How_did_Lincoln_Pharma_India_Glycols_and_Jubilant_FoodWorks_perform_in_Q1_FY27\" title=\"How did Lincoln Pharma, India Glycols and Jubilant FoodWorks perform in Q1 FY27?\">How did Lincoln Pharma, India Glycols and Jubilant FoodWorks perform in Q1 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#Do_formulation_maker_glycol_producer_and_pizza_chain_stocks_pay_dividends\" title=\"Do formulation maker, glycol producer and pizza chain stocks pay dividends?\">Do formulation maker, glycol producer and pizza chain stocks pay dividends?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/formulation-maker-glycol-producer-and-pizza-chain-stocks-roadmap-compass-list\/#How_can_I_invest_in_formulation_maker_glycol_producer_and_pizza_chain_stocks_in_India\" title=\"How can I invest in formulation maker, glycol producer and pizza chain stocks in India?\">How can I invest in formulation maker, glycol producer and pizza chain stocks in India?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks\"><\/span><strong>What Are Formulation Maker, Glycol Producer and Pizza Chain Stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Formulation maker, glycol producer and pizza chain stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks_at_a_Glance\"><\/span><strong>Formulation Maker, Glycol Producer and Pizza Chain Stocks at a Glance<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares size, valuation, return on equity and debt for the three formulation maker, glycol producer and pizza chain stocks as of the 14 Oct 2026 close.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Company<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Industry P\/E<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">ROE<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/lincoln\/lincoln-pharmaceuticals-ltd-share-price-today\">Lincoln Pharmaceuticals<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">542.90<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">1,123<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.64<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">37.59<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.60%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/indiaglyco\/india-glycols-ltd-share-price-today\">India Glycols<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">349.85<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2,397<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.58<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">54.53<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.98%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.58<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\"><a href=\"https:\/\/univest.in\/stocks\/jublfood\/jubilant-foodworks-ltd-share-price-today\">Jubilant FoodWorks<\/a><\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">425.70<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">28,248<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.77<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">61.79<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.69%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2.14<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Among healthcare, chemicals and consumer stocks, valuations sit close to their industry P\/E multiples.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Do_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks_Have_a_Strong_Roadmap_in_India\"><\/span><strong>Why Do Formulation Maker, Glycol Producer and Pizza Chain Stocks Have a Strong Roadmap in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Formulation maker, glycol producer and pizza chain stocks have a strong roadmap in India because export demand for medicines, ethanol blending and eating out keep adding volumes for these firms. Three drivers stand out.<\/p>\n<ul>\n<li><strong>Pharma exports:<\/strong> Emerging markets add demand for formulations.<\/li>\n<li><strong>Renewable chemicals:<\/strong> Ethanol and bio-based chemicals gain policy support.<\/li>\n<li><strong>Eating out:<\/strong> Quick-service outlets reach more towns.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Lincoln_Pharmaceuticals_Formulations_for_India_and_Export_Markets_Build_the_Next_Leg\"><\/span><strong>Lincoln Pharmaceuticals: Formulations for India and Export Markets Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Lincoln Pharma&#8217;s roadmap rests on formulations sold in India and emerging export markets, with a broad product list supporting revenue.<\/p>\n<p>Revenue grew from Rs 482.12 crore in FY22 to Rs 704.48 crore in FY26, a 46.1% rise, and FY26 revenue was 9.1% higher than FY25. FY26 net profit rose 6.7% to Rs 87.89 crore. Over four years, net profit rose from Rs 69.36 crore in FY22 to Rs 87.89 crore. In Q1 FY27, revenue grew 19.0% to Rs 201.54 crore, and net profit rose 30.9% to Rs 36.23 crore.<\/p>\n<p>Debt to equity is 0.01 and return on equity is 11.60%. The dividend yield is 0.32%. At a P\/E of 11.64 against an industry P\/E of 37.59, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 11.64 against an industry P\/E of 37.59 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"India_Glycols_Green_Chemicals_and_Ethanol_Build_the_Next_Leg\"><\/span><strong>India Glycols: Green Chemicals and Ethanol Build the Next Leg<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>India Glycols&#8217; roadmap rests on glycols, spirits and ethanol, and specialty chemicals made from renewable feedstock, with ethanol blending and chemical demand supporting volumes.<\/p>\n<p>Revenue grew from Rs 2,889.84 crore in FY22 to Rs 4,216.34 crore in FY26, a 45.9% rise, and FY26 revenue was 11.5% higher than FY25. FY26 net profit rose 26.8% to Rs 292.76 crore. In Q1 FY27, revenue grew 19.3% to Rs 2,988.82 crore, and net profit rose 32.2% to Rs 96.83 crore. Operating margin was 7.12% in FY26.<\/p>\n<p>Debt to equity is 0.58 and return on equity is 9.98%. FY26 operating cash flow was Rs 769.16 crore against capital expenditure of Rs 823.48 crore. India Glycols paid a dividend of Rs 7.5 per share for FY26, a yield of 2.10%. At a P\/E of 7.58 against an industry P\/E of 54.53, the stock trades below its industry multiple.<\/p>\n<p>What to watch: The P\/E of 7.58 against an industry P\/E of 54.53 leaves valuation less stretched, so the next quarters&#8217; growth is the figure to follow.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Jubilant_FoodWorks_Dominos_Store_Network_Anchors_the_Roadmap\"><\/span><strong>Jubilant FoodWorks: Domino&#8217;s Store Network Anchors the Roadmap<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Jubilant FoodWorks&#8217; roadmap rests on Domino&#8217;s Pizza stores across India and neighbouring markets, along with newer food brands, with store additions and delivery reach supporting sales.<\/p>\n<p>Revenue grew from Rs 4,437.48 crore in FY22 to Rs 9,586.64 crore in FY26, a 116.0% rise, and FY26 revenue was 17.2% higher than FY25. FY26 net profit rose 54.4% to Rs 386.03 crore. In Q1 FY27, revenue grew 13.6% to Rs 2,588.34 crore, and net profit rose 6.0% to Rs 100.03 crore. Operating margin was 20.96% in FY26 and 20.37% in Q1 FY27 against 20.21% a year earlier.<\/p>\n<p>Debt to equity is 2.14 and return on equity is 18.69%. FY26 operating cash flow was Rs 1,893.55 crore against capital expenditure of Rs 1,009.93 crore. Jubilant FoodWorks paid a dividend of Rs 1.2 per share for FY26, a yield of 0.28%. At a P\/E of 62.77 against an industry P\/E of 61.79, the stock trades in line with its industry multiple.<\/p>\n<p>What to watch: Debt to equity of 2.14 is on the higher side, and net profit margin is only 4.0%, so small cost changes move earnings.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Best_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks_in_India_Lincoln_Pharma_vs_India_Glycols_vs_Jubilant_FoodWorks_on_Key_Financials\"><\/span><strong>Best Formulation Maker, Glycol Producer and Pizza Chain Stocks in India: Lincoln Pharma vs India Glycols vs Jubilant FoodWorks on Key Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among the best formulation maker, glycol producer and pizza chain stocks in India, Lincoln Pharma leads on the lowest debt to equity; India Glycols leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth; Jubilant FoodWorks leads on FY26 revenue growth and FY26 net profit growth. The table puts the numbers side by side.<\/p>\n<div style=\"overflow-x:auto;\">\n<table style=\"border-collapse:collapse;width:100%;\">\n<tr>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Metric<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Lincoln Pharma<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">India Glycols<\/th>\n<th style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;background:#F0F4F8;\">Jubilant FoodWorks<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">704.48<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">4,216.34<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9,586.64<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 revenue growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.1%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.5%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">17.2%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit (Rs Cr)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">87.89<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">292.76<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">386.03<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">FY26 net profit growth<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.7%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">26.8%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">54.4%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 revenue growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.0%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">19.3%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">13.6%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Q1 FY27 net profit growth (YoY)<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">30.9%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">32.2%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">6.0%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Return on equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.60%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">9.98%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">18.69%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">P\/E ratio<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">11.64<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">7.58<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">62.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Debt to equity<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.01<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.58<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2.14<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">Dividend yield<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.32%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">2.10%<\/td>\n<td style=\"border:1px solid #DDDDDD;padding:8px 10px;text-align:left;\">0.28%<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Evaluate_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks_to_Buy_Before_You_Invest\"><\/span><strong>How to Evaluate Formulation Maker, Glycol Producer and Pizza Chain Stocks to Buy Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>A short checklist keeps the research consistent when you screen formulation maker, glycol producer and pizza chain stocks and shortlist formulation maker, glycol producer and pizza chain stocks to buy.<\/p>\n<ol>\n<li>Compare each stock&#8217;s P\/E with its industry P\/E, which differs by company here.<\/li>\n<li>Check revenue growth, operating margin and cash flow together.<\/li>\n<li>Check whether revenue growth is turning into profit growth, not only sales.<\/li>\n<li>Read operating cash flow against capital expenditure to see how growth is funded.<\/li>\n<li>Watch debt to equity and interest cover before sizing a position.<\/li>\n<li>Spread exposure across companies and business lines instead of one demand cycle.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these formulation maker, glycol producer and pizza chain stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Consider_Before_Investing_in_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks\"><\/span><strong>Risks to Consider Before Investing in Formulation Maker, Glycol Producer and Pizza Chain Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Debt and cash flow:<\/strong> Jubilant FoodWorks has debt to equity of 2.14.<\/li>\n<li><strong>Consumer demand:<\/strong> Spending patterns can shift sales between quarters.<\/li>\n<li><strong>Input costs:<\/strong> Changes in raw material prices can affect margins.<\/li>\n<li><strong>Quarterly trends:<\/strong> A single weak quarter can change near-term earnings, so track results every quarter.<\/li>\n<\/ul>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Lincoln Pharma, India Glycols and Jubilant FoodWorks live.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_Take_Which_Stock_Has_the_Strongest_Roadmap\"><\/span><strong>Final Take: Which Stock Has the Strongest Roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These three healthcare, chemicals and consumer stocks cover formulations, glycols and quick-service restaurants. Lincoln Pharma leads on the lowest debt to equity; India Glycols leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth; Jubilant FoodWorks leads on FY26 revenue growth and FY26 net profit growth.<\/p>\n<p>Across formulation maker, glycol producer and pizza chain stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the formulation maker, glycol producer and pizza chain stocks to buy discussed here.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Formulation_Maker_Glycol_Producer_and_Pizza_Chain_Stocks\"><\/span><strong>FAQs on Formulation Maker, Glycol Producer and Pizza Chain Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_formulation_maker_glycol_producer_and_pizza_chain_stocks_in_India_with_a_strong_roadmap\"><\/span><strong>Which are the best formulation maker, glycol producer and pizza chain stocks in India with a strong roadmap?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lincoln Pharmaceuticals, India Glycols and Jubilant FoodWorks stand out for their roadmaps in formulations, glycols and quick-service restaurants. FY26 revenue growth was 9.1% at Lincoln Pharma, 11.5% at India Glycols and 17.2% at Jubilant FoodWorks, and return on equity ranges from 9.98% to 18.69%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Lincoln_Pharmaceuticals_a_good_stock_to_buy_now\"><\/span><strong>Is Lincoln Pharmaceuticals a good stock to buy now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lincoln Pharmaceuticals has a debt to equity ratio of 0.01, a return on equity of 11.60% and a P\/E of 11.64 against an industry P\/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_PE_ratio_of_Lincoln_Pharma_India_Glycols_and_Jubilant_FoodWorks\"><\/span><strong>What is the P\/E ratio of Lincoln Pharma, India Glycols and Jubilant FoodWorks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The P\/E ratio is 11.64 for Lincoln Pharma (industry 37.59), 7.58 for India Glycols (industry 54.53) and 62.77 for Jubilant FoodWorks (industry 61.79). Only Jubilant FoodWorks trades at or above the industry multiple.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_of_these_formulation_maker_glycol_producer_and_pizza_chain_stocks_has_the_highest_return_on_equity\"><\/span><strong>Which of these formulation maker, glycol producer and pizza chain stocks has the highest return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Jubilant FoodWorks has the highest return on equity at 18.69%, followed by Lincoln Pharmaceuticals at 11.60% and India Glycols at 9.98%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_formulation_maker_glycol_producer_and_pizza_chain_stocks\"><\/span><strong>What are the risks of investing in formulation maker, glycol producer and pizza chain stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are debt and cash flow, consumer demand, input costs and quarterly trends. Jubilant FoodWorks has debt to equity of 2.14.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Lincoln_Pharma_India_Glycols_and_Jubilant_FoodWorks_perform_in_Q1_FY27\"><\/span><strong>How did Lincoln Pharma, India Glycols and Jubilant FoodWorks perform in Q1 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lincoln Pharmaceuticals reported revenue of Rs 201.54 crore, up 19.0% year on year, and net profit rose 30.9% to Rs 36.23 crore. India Glycols reported revenue of Rs 2,988.82 crore, up 19.3% year on year, and net profit rose 32.2% to Rs 96.83 crore. Jubilant FoodWorks reported revenue of Rs 2,588.34 crore, up 13.6% year on year, and net profit rose 6.0% to Rs 100.03 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Do_formulation_maker_glycol_producer_and_pizza_chain_stocks_pay_dividends\"><\/span><strong>Do formulation maker, glycol producer and pizza chain stocks pay dividends?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, all three companies pay dividends. The dividend yield is 0.32% for Lincoln Pharma, 2.10% for India Glycols and 0.28% for Jubilant FoodWorks, based on dividends declared for FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_can_I_invest_in_formulation_maker_glycol_producer_and_pizza_chain_stocks_in_India\"><\/span><strong>How can I invest in formulation maker, glycol producer and pizza chain stocks in India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> You can buy formulation maker, glycol producer and pizza chain stocks through a demat and trading account on NSE or BSE after checking each company&#8217;s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best formulation maker, glycol producer and pizza chain stocks in India with a strong roadmap?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Lincoln Pharmaceuticals, India Glycols and Jubilant FoodWorks stand out for their roadmaps in formulations, glycols and quick-service restaurants. FY26 revenue growth was 9.1% at Lincoln Pharma, 11.5% at India Glycols and 17.2% at Jubilant FoodWorks, and return on equity ranges from 9.98% to 18.69%.\"}},{\"@type\":\"Question\",\"name\":\"Is Lincoln Pharmaceuticals a good stock to buy now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Lincoln Pharmaceuticals has a debt to equity ratio of 0.01, a return on equity of 11.60% and a P\/E of 11.64 against an industry P\/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.\"}},{\"@type\":\"Question\",\"name\":\"What is the P\/E ratio of Lincoln Pharma, India Glycols and Jubilant FoodWorks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The P\/E ratio is 11.64 for Lincoln Pharma (industry 37.59), 7.58 for India Glycols (industry 54.53) and 62.77 for Jubilant FoodWorks (industry 61.79). Only Jubilant FoodWorks trades at or above the industry multiple.\"}},{\"@type\":\"Question\",\"name\":\"Which of these formulation maker, glycol producer and pizza chain stocks has the highest return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Jubilant FoodWorks has the highest return on equity at 18.69%, followed by Lincoln Pharmaceuticals at 11.60% and India Glycols at 9.98%.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in formulation maker, glycol producer and pizza chain stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are debt and cash flow, consumer demand, input costs and quarterly trends. Jubilant FoodWorks has debt to equity of 2.14.\"}},{\"@type\":\"Question\",\"name\":\"How did Lincoln Pharma, India Glycols and Jubilant FoodWorks perform in Q1 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Lincoln Pharmaceuticals reported revenue of Rs 201.54 crore, up 19.0% year on year, and net profit rose 30.9% to Rs 36.23 crore. India Glycols reported revenue of Rs 2,988.82 crore, up 19.3% year on year, and net profit rose 32.2% to Rs 96.83 crore. Jubilant FoodWorks reported revenue of Rs 2,588.34 crore, up 13.6% year on year, and net profit rose 6.0% to Rs 100.03 crore.\"}},{\"@type\":\"Question\",\"name\":\"Do formulation maker, glycol producer and pizza chain stocks pay dividends?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, all three companies pay dividends. The dividend yield is 0.32% for Lincoln Pharma, 2.10% for India Glycols and 0.28% for Jubilant FoodWorks, based on dividends declared for FY26.\"}},{\"@type\":\"Question\",\"name\":\"How can I invest in formulation maker, glycol producer and pizza chain stocks in India?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"You can buy formulation maker, glycol producer and pizza chain stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Lincoln Pharmaceuticals, India Glycols and Jubilant FoodWorks compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.<\/p>\n","protected":false},"author":29,"featured_media":310210,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[12372,12373,12374,11010,7498,11169],"class_list":["post-310211","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-formulation-maker","tag-glycol-producer-and-pizza-chain-stocks","tag-glycol-producer-and-pizza-chain-stocks-to-buy","tag-india-glycols","tag-jubilant-foodworks","tag-lincoln-pharmaceuticals"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["310210"],"rank_math_title":["Formulation Maker, Glycol Producer and Pizza Chain Stocks"],"rank_math_description":["Formulation maker, glycol producer and pizza chain stocks with a strong roadmap compared on growth, margins, valuation and risks."],"rank_math_focus_keyword":["formulation maker, glycol producer and pizza chain stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/3-formulation-maker-glycol-producer-and-pizza-chain-stocks-with-a-strong-future.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/310211","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=310211"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/310211\/revisions"}],"predecessor-version":[{"id":310212,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/310211\/revisions\/310212"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/310210"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=310211"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=310211"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=310211"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}